Skip to main content
. Author manuscript; available in PMC: 2019 Jul 24.
Published in final edited form as: Phys Biol. 2019 Jun 19;16(4):041005. doi: 10.1088/1478-3975/ab1a09

Figure 10.

Figure 10.

Conventional high dose therapy (top) maximally selects for resistant phenotypes (pink). Adaptive therapy (bottom) maintains a small population of cells that are sensitive to treatment. While the resistant cells survive, the cost of resistance renders them less fit in the absence of therapy. Thus, sensitive cells return when therapy is removed, suppressing growth of the resistant population.